Posted by Michael Wonder on 28 Jul 2023
Critics wary over plans to fast track UK drug approval model
27 July 2023 - The UK regulator’s proposal to piggyback on other countries’ decisions might lead to an over-reliance on their systems.
Critics of a plan by UK regulators to fast-track appraisals of new medicines that are already approved in other countries are sceptical about claims that it will boost life-science investment. They also warn that it could foster an over-reliance on approval processes in the United States and elsewhere.
